Artiva
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5505 Morehouse Dr Ste 100, San Diego, Ca...Phone Number
(858) 267-4467Website
www.artivabio.comRevenue
-Industry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About Artiva
Founded in 2019, Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. The company is headquartered in San Diego, California.Explore more
Artiva Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artiva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Artiva had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Artiva
Funding: Get notified immidiatlly once Artiva has new funding data
Product Launch: Get notified when Artiva launches new products
Artiva, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Artiva has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Artiva recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Artiva is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Artiva as Masked Content
Find 2 more new buyers
Compare Similar Companies to Artiva
Compare insights from companies similar to Artiva, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artiva is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Artiva is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Artiva.
Artiva financials insights
Gather financial insights about Artiva, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$78M
2021
Series B
$120M
Artiva Tech Stack
A closer look at the technologies used by Artiva
Most Recent Scoops
Person-Based
Medical Research, Clinical Operations
Person-Based
Regulations
Open Position
Project
Artiva has developed a scalable manufacturing process for AlloNK cells whereby a single umbilical cord unit can yield sufficient NK cells to treat over 500 patients at the current Phase III dosing regimen, with the company's existing 9,000 square-foot facility capable of treating up to 500 patients per year at full capacity.
Manufacturing Operations
Open Position
Artiva News & Media
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in SeptemberArtiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business HighlightsArtiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that the Compensation Committee of its Board of Directors approved new employee inducement grants covering an aggregate of 288,800 restricted stock units (the “Inducement Grants”) for 17 new employees.Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that Artiva management will participate in a fireside chat at the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference on Tuesday, June 30, 2026, at 3:30 pm EDT.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Artiva
Sign Up For FreeTo access detailed company insights
Founded in 2019, Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. The company is headquartered in San Diego, California.... Read More
